speb/financial-data huggingface dataset:
MLBIO.PA income_statement (annual, 2021-12-31) — Other Operating Expenses: 3914623.00
MLBIO.PA balance_sheet (annual, 2021-12-31) — Other Receivables: 46000.00
MLBIO.PA balance_sheet (annual, 2021-12-31) — Other Short Term Investments: 73058.00
MLBIO.PA income_statement (annual, 2021-12-31) — Other Special Charges: -25596.00
MLBIO.PA income_statement (annual, 2021-12-31) — Otherunder Preferred Stock Dividend: 0.00
MLBIO.PA balance_sheet (annual, 2021-12-31) — Payables: 405400.00
MLBIO.PA income_statement (annual, 2021-12-31) — Pretax Income: 700783.00
MLBIO.PA income_statement (annual, 2021-12-31) — Reconciled Cost Of Revenue: 1175550.00
MLBIO.PA income_statement (annual, 2021-12-31) — Reconciled Depreciation: 265774.00
MLBIO.PA balance_sheet (annual, 2021-12-31) — Retained Earnings: 564182.00
MLBIO.PA balance_sheet (annual, 2021-12-31) — Share Issued: 2578500.00
MLBIO.PA income_statement (annual, 2021-12-31) — Special Income Charges: 25596.00
MLBIO.PA balance_sheet (annual, 2021-12-31) — Stockholders Equity: 5136233.00
MLBIO.PA balance_sheet (annual, 2021-12-31) — Tangible Book Value: 3528941.00
MLBIO.PA income_statement (annual, 2021-12-31) — Tax Effect Of Unusual Items: 4989.36
MLBIO.PA income_statement (annual, 2021-12-31) — Tax Provision: 136601.64
MLBIO.PA income_statement (annual, 2021-12-31) — Tax Rate For Calcs: 0.19
MLBIO.PA balance_sheet (annual, 2021-12-31) — Total Assets: 9434015.00
MLBIO.PA balance_sheet (annual, 2021-12-31) — Total Capitalization: 7412986.00
MLBIO.PA balance_sheet (annual, 2021-12-31) — Total Debt: 3855340.00
MLBIO.PA balance_sheet (annual, 2021-12-31) — Total Equity Gross Minority Interest: 5136233.00
MLBIO.PA income_statement (annual, 2021-12-31) — Total Expenses: 6019679.00
MLBIO.PA balance_sheet (annual, 2021-12-31) — Total Liabilities Net Minority Interest: 4297782.00
MLBIO.PA balance_sheet (annual, 2021-12-31) — Total Non Current Assets: 6047590.00
MLBIO.PA balance_sheet (annual, 2021-12-31) — Total Non Current Liabilities Net Minority Interest: 2313795.00
MLBIO.PA income_statement (annual, 2021-12-31) — Total Operating Income As Reported: 795857.00
MLBIO.PA income_statement (annual, 2021-12-31) — Total Unusual Items: 25596.00
MLBIO.PA income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: 25596.00
MLBIO.PA balance_sheet (annual, 2021-12-31) — Working Capital: 1402438.00
MLBIO.PA income_statement (annual, 2022-12-31) — +Operating Expense: 5787601.00
MLBIO.PA income_statement (annual, 2022-12-31) — +Total Revenue: 6983261.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Accounts Payable: 92419.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Accounts Receivable: 58298.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -1940165.00
MLBIO.PA income_statement (annual, 2022-12-31) — Basic Average Shares: 2578500.00
MLBIO.PA income_statement (annual, 2022-12-31) — Basic EPS: 0.19
MLBIO.PA cash_flow (annual, 2022-12-31) — Beginning Cash Position: 60698.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Capital Expenditure: -2163332.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 0.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Capital Stock: 5157000.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 65374.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 88709.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Cash Financial: 65375.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Change In Inventory: -1920100.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 15353.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 1401403.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Change In Payable: -4676.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Change In Receivables: -222427.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Change In Working Capital: -730447.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Changes In Cash: 4677.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Common Stock: 5157000.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Common Stock Equity: 6616329.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Common Stock Issuance: 980840.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Common Stock Payments: 0.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Construction In Progress: 874079.00
MLBIO.PA income_statement (annual, 2022-12-31) — Cost Of Revenue: 561458.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Current Assets: 5518462.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 0.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Current Debt: 2551746.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 2551746.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Current Liabilities: 3387032.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Depreciation: 301993.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 301993.00
MLBIO.PA income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 301993.00
MLBIO.PA income_statement (annual, 2022-12-31) — Depreciation Income Statement: 301993.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 2076774.00
MLBIO.PA income_statement (annual, 2022-12-31) — Diluted Average Shares: 2578500.00
MLBIO.PA income_statement (annual, 2022-12-31) — Diluted EPS: 0.19
MLBIO.PA income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 500250.00
MLBIO.PA income_statement (annual, 2022-12-31) — EBIT: 638221.00
MLBIO.PA income_statement (annual, 2022-12-31) — EBITDA: 940214.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 0.00
MLBIO.PA cash_flow (annual, 2022-12-31) — End Cash Position: 65374.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Financial Assets: 85.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Financing Cash Flow: 2131525.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Fixed Assets Revaluation Reserve: -994.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Free Cash Flow: -2126621.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -753.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 2105851.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Gross PPE: 7358283.00
MLBIO.PA income_statement (annual, 2022-12-31) — Gross Profit: 6421803.00
MLBIO.PA income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: -753.00
MLBIO.PA income_statement (annual, 2022-12-31) — Interest Expense: 68176.00
MLBIO.PA income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 68176.00
MLBIO.PA income_statement (annual, 2022-12-31) — Interest Income: 11.00
MLBIO.PA income_statement (annual, 2022-12-31) — Interest Income Non Operating: 11.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Interest Paid Cfo: -70527.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Interest Received Cfo: 5618.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Inventory: 4087613.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Invested Capital: 10476563.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Investing Cash Flow: -2163559.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 45392.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 980840.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Issuance Of Debt: 2729455.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 0.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Long Term Debt: 1308488.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1308488.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 2729455.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -1578770.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 356900.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 5216707.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 980840.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Net Debt: 3794860.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: -3256.00
MLBIO.PA income_statement (annual, 2022-12-31) — Net Income: 500250.00
MLBIO.PA income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 500250.00
MLBIO.PA income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 500250.00
MLBIO.PA income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 500250.00
MLBIO.PA income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 500250.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 570045.00
MLBIO.PA income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 500250.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -498256.00
MLBIO.PA income_statement (annual, 2022-12-31) — Net Interest Income: -68165.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -227.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 1150685.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 1150685.00
MLBIO.PA income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -68165.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Net PPE: 5418118.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -1665076.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 4510478.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 23117.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 79218.00
MLBIO.PA income_statement (annual, 2022-12-31) — Normalized EBITDA: 939461.00
MLBIO.PA income_statement (annual, 2022-12-31) — Normalized Income: 499589.20
MLBIO.PA cash_flow (annual, 2022-12-31) — Operating Cash Flow: 36711.00
MLBIO.PA income_statement (annual, 2022-12-31) — Operating Income: 634202.00
MLBIO.PA income_statement (annual, 2022-12-31) — Operating Revenue: 6983261.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 2578500.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Other Cash Adjustment Outside Changein Cash: -1.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Other Current Assets: 1.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Other Current Liabilities: -1.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 2105851.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Other Investments: 45307.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Other Non Cash Items: 64909.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: -1.00
MLBIO.PA income_statement (annual, 2022-12-31) — Other Operating Expenses: 4794826.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Other Payable: 229697.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Other Receivables: 1283841.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 23335.00
MLBIO.PA income_statement (annual, 2022-12-31) — Other Special Charges: -753.00
MLBIO.PA income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Payables: 370752.00
MLBIO.PA income_statement (annual, 2022-12-31) — Pretax Income: 570045.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Properties: 1267497.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -498256.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Purchase Of Investment: -227.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Purchase Of PPE: -1665076.00
MLBIO.PA income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 561458.00
MLBIO.PA income_statement (annual, 2022-12-31) — Reconciled Depreciation: 301993.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Repayment Of Debt: -1578770.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: 0.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Retained Earnings: 500250.00
MLBIO.PA cash_flow (annual, 2022-12-31) — Sale Of Investment: 0.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Share Issued: 2578500.00
MLBIO.PA income_statement (annual, 2022-12-31) — Special Income Charges: 753.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Stockholders Equity: 6616329.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Tangible Book Value: 4510478.00
MLBIO.PA income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 92.20
MLBIO.PA income_statement (annual, 2022-12-31) — Tax Provision: 69795.00
MLBIO.PA income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.12
MLBIO.PA cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -100871.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Total Assets: 13467840.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Total Capitalization: 7924817.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Total Debt: 3860234.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 6616329.00
MLBIO.PA income_statement (annual, 2022-12-31) — Total Expenses: 6349059.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 6851511.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 7949378.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 3464479.00
MLBIO.PA income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 634954.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Total Tax Payable: 48636.00
MLBIO.PA income_statement (annual, 2022-12-31) — Total Unusual Items: 753.00
MLBIO.PA income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 753.00
MLBIO.PA balance_sheet (annual, 2022-12-31) — Working Capital: 2131430.00
MLBIO.PA income_statement (annual, 2023-12-31) — +Operating Expense: 6055479.41
MLBIO.PA income_statement (annual, 2023-12-31) — +Total Revenue: 7198359.09
MLBIO.PA balance_sheet (annual, 2023-12-31) — Accounts Payable: 15148.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Accounts Receivable: 106189.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -2197985.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Beginning Cash Position: 65374.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Capital Expenditure: -3599006.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 1145000.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Capital Stock: 5157000.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 367087.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 409138.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Cash Financial: 367088.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Change In Inventory: -203751.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -26016.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 97567.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Change In Payable: -65287.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Change In Receivables: 1181743.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Change In Working Capital: 984256.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Changes In Cash: 301713.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Common Stock: 5157000.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Common Stock Equity: 6904103.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Common Stock Issuance: 27217.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Common Stock Payments: -157382.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Construction In Progress: 2453137.00
MLBIO.PA income_statement (annual, 2023-12-31) — Cost Of Revenue: 552829.50
MLBIO.PA balance_sheet (annual, 2023-12-31) — Current Assets: 4898910.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 71593.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Current Debt: 2902836.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 2974429.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Current Liabilities: 3446568.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Depreciation: 295411.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 295411.00
MLBIO.PA income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 295410.88
MLBIO.PA income_statement (annual, 2023-12-31) — Depreciation Income Statement: 295410.88
MLBIO.PA balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 3279493.00
MLBIO.PA income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 416803.76
MLBIO.PA income_statement (annual, 2023-12-31) — EBIT: 670797.09
MLBIO.PA income_statement (annual, 2023-12-31) — EBITDA: 966208.09
MLBIO.PA cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 0.00
MLBIO.PA cash_flow (annual, 2023-12-31) — End Cash Position: 367087.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Financial Assets: 85.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Financing Cash Flow: 2245687.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Free Cash Flow: -1933970.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -54275.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 3490210.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Gross PPE: 9562206.00
MLBIO.PA income_statement (annual, 2023-12-31) — Gross Profit: 6645529.59
MLBIO.PA balance_sheet (annual, 2023-12-31) — Held To Maturity Securities: 306.00
MLBIO.PA income_statement (annual, 2023-12-31) — Interest Expense: 178100.25
MLBIO.PA income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 178100.25
MLBIO.PA income_statement (annual, 2023-12-31) — Interest Income: 26850.00
MLBIO.PA income_statement (annual, 2023-12-31) — Interest Income Non Operating: 26850.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Interest Paid Cfo: -179208.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Interest Received Cfo: 27579.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Inventory: 4291364.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Invested Capital: 11172928.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Investing Cash Flow: -3609010.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 306.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 27217.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Issuance Of Debt: 5248237.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 1073407.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Long Term Debt: 1365989.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 2439396.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 5248237.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -2872384.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 356900.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 5841572.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -130165.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Net Debt: 3901738.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 379.00
MLBIO.PA income_statement (annual, 2023-12-31) — Net Income: 416803.76
MLBIO.PA income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 416803.76
MLBIO.PA income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 416803.76
MLBIO.PA income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 416803.76
MLBIO.PA income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 416803.76
MLBIO.PA cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 492697.00
MLBIO.PA income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 416803.76
MLBIO.PA cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -1392833.00
MLBIO.PA income_statement (annual, 2023-12-31) — Net Interest Income: -178100.25
MLBIO.PA cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -12254.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 2375853.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 2375853.00
MLBIO.PA income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -178100.25
MLBIO.PA cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -1.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Net PPE: 7364221.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -2203923.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 3413893.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 13857.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 121443.00
MLBIO.PA income_statement (annual, 2023-12-31) — Normalized EBITDA: 885082.39
MLBIO.PA income_statement (annual, 2023-12-31) — Normalized Income: 348174.34
MLBIO.PA cash_flow (annual, 2023-12-31) — Operating Cash Flow: 1665036.00
MLBIO.PA income_statement (annual, 2023-12-31) — Operating Income: 590050.18
MLBIO.PA income_statement (annual, 2023-12-31) — Operating Revenue: 7198359.09
MLBIO.PA balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 2578500.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Other Current Liabilities: -1.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 3490210.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Other Investments: 66515.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Other Non Cash Items: 151629.00
MLBIO.PA income_statement (annual, 2023-12-31) — Other Operating Expenses: 5009566.96
MLBIO.PA balance_sheet (annual, 2023-12-31) — Other Payable: 337666.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Other Receivables: 92219.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 42051.00
MLBIO.PA income_statement (annual, 2023-12-31) — Other Special Charges: -54275.32
MLBIO.PA income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Payables: 372806.00
MLBIO.PA income_statement (annual, 2023-12-31) — Pretax Income: 492696.84
MLBIO.PA balance_sheet (annual, 2023-12-31) — Properties: 1267497.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -1395083.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Purchase Of Investment: -21514.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Purchase Of PPE: -2203923.00
MLBIO.PA income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 552829.50
MLBIO.PA income_statement (annual, 2023-12-31) — Reconciled Depreciation: 295411.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Repayment Of Debt: -2872384.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -157382.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Retained Earnings: 416804.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Sale Of Intangibles: 2250.00
MLBIO.PA cash_flow (annual, 2023-12-31) — Sale Of Investment: 9260.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Share Issued: 2578500.00
MLBIO.PA income_statement (annual, 2023-12-31) — Special Income Charges: 54275.32
MLBIO.PA balance_sheet (annual, 2023-12-31) — Stockholders Equity: 6904103.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Tangible Book Value: 3413893.00
MLBIO.PA income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 12496.28
MLBIO.PA income_statement (annual, 2023-12-31) — Tax Provision: 75893.08
MLBIO.PA income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.15
MLBIO.PA cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -53431.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Total Assets: 16191003.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Total Capitalization: 8270092.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Total Debt: 5413825.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 6904103.00
MLBIO.PA income_statement (annual, 2023-12-31) — Total Expenses: 6608308.91
MLBIO.PA balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 9286900.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 11292094.00
MLBIO.PA balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 5840332.00
MLBIO.PA income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 644325.50
MLBIO.PA balance_sheet (annual, 2023-12-31) — Total Tax Payable: 19992.00
MLBIO.PA income_statement (annual, 2023-12-31) — Total Unusual Items: 81125.70
MLBIO.PA income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 81125.70
MLBIO.PA balance_sheet (annual, 2023-12-31) — Working Capital: 1452342.00
MLBON.PA income_statement (annual, 2022-12-31) — +Operating Expense: 327558.71
MLBON.PA income_statement (annual, 2022-12-31) — +Total Revenue: 277397.63
MLBON.PA balance_sheet (annual, 2022-12-31) — Accounts Payable: 364657.65
MLBON.PA balance_sheet (annual, 2022-12-31) — Accounts Receivable: 129816.99
MLBON.PA income_statement (annual, 2022-12-31) — Basic EPS: -5.64
MLBON.PA balance_sheet (annual, 2022-12-31) — Capital Stock: 7063200.00
MLBON.PA balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 393.08
MLBON.PA balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 393.08
MLBON.PA balance_sheet (annual, 2022-12-31) — Cash Financial: 393.08
MLBON.PA balance_sheet (annual, 2022-12-31) — Common Stock: 7063200.00
MLBON.PA balance_sheet (annual, 2022-12-31) — Common Stock Equity: 3725628.16
MLBON.PA income_statement (annual, 2022-12-31) — Cost Of Revenue: 267349.33
MLBON.PA balance_sheet (annual, 2022-12-31) — Current Assets: 170599.95
MLBON.PA balance_sheet (annual, 2022-12-31) — Current Debt: 0.00
MLBON.PA balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 0.00
MLBON.PA balance_sheet (annual, 2022-12-31) — Current Liabilities: 444971.79
MLBON.PA income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 50034.99
MLBON.PA income_statement (annual, 2022-12-31) — Depreciation Income Statement: 50034.99
MLBON.PA income_statement (annual, 2022-12-31) — Diluted EPS: -5.64
MLBON.PA income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -3318063.10
MLBON.PA income_statement (annual, 2022-12-31) — EBIT: -317510.41
MLBON.PA income_statement (annual, 2022-12-31) — EBITDA: -267475.42
MLBON.PA balance_sheet (annual, 2022-12-31) — Finished Goods: 23811.50
MLBON.PA income_statement (annual, 2022-12-31) — Gross Profit: 10048.30
MLBON.PA income_statement (annual, 2022-12-31) — Interest Expense: 3000552.69
MLBON.PA income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 3000552.69
MLBON.PA balance_sheet (annual, 2022-12-31) — Inventory: 23811.50
MLBON.PA balance_sheet (annual, 2022-12-31) — Invested Capital: 3725628.16
MLBON.PA balance_sheet (annual, 2022-12-31) — Investments In Other Ventures Under Equity Method: 4000000.00
MLBON.PA balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 4000000.00
MLBON.PA balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 4000000.00
MLBON.PA income_statement (annual, 2022-12-31) — Net Income: -3318063.10
MLBON.PA income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -3318063.10
MLBON.PA income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -3318063.10
MLBON.PA income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -3318063.10
MLBON.PA income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -3318063.10
MLBON.PA income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -3318063.10
MLBON.PA income_statement (annual, 2022-12-31) — Net Interest Income: -3000552.69
MLBON.PA income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -3000552.69
MLBON.PA balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 3725628.16
MLBON.PA income_statement (annual, 2022-12-31) — Normalized EBITDA: -267475.42
MLBON.PA income_statement (annual, 2022-12-31) — Normalized Income: -3318063.10
MLBON.PA income_statement (annual, 2022-12-31) — Operating Income: -317510.41
MLBON.PA income_statement (annual, 2022-12-31) — Operating Revenue: 277397.63
MLBON.PA balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 2040.68
MLBON.PA income_statement (annual, 2022-12-31) — Other Operating Expenses: 221462.56
MLBON.PA balance_sheet (annual, 2022-12-31) — Other Receivables: 16578.38
MLBON.PA income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
MLBON.PA balance_sheet (annual, 2022-12-31) — Payables: 376249.65
MLBON.PA income_statement (annual, 2022-12-31) — Pretax Income: -3318063.10
MLBON.PA income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 267349.33
MLBON.PA income_statement (annual, 2022-12-31) — Reconciled Depreciation: 50034.99
MLBON.PA balance_sheet (annual, 2022-12-31) — Retained Earnings: -3344912.33
MLBON.PA balance_sheet (annual, 2022-12-31) — Stockholders Equity: 3725628.16
MLBON.PA balance_sheet (annual, 2022-12-31) — Tangible Book Value: 3725628.16
MLBON.PA income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
MLBON.PA income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
MLBON.PA balance_sheet (annual, 2022-12-31) — Total Assets: 4170599.95
MLBON.PA balance_sheet (annual, 2022-12-31) — Total Capitalization: 3725628.16
MLBON.PA balance_sheet (annual, 2022-12-31) — Total Debt: 0.00
MLBON.PA balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 3725628.16
MLBON.PA income_statement (annual, 2022-12-31) — Total Expenses: 594908.04
MLBON.PA balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 444971.79
MLBON.PA balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 4000000.00
MLBON.PA balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
MLBON.PA income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -317510.41
MLBON.PA balance_sheet (annual, 2022-12-31) — Total Tax Payable: 11592.00
MLBON.PA balance_sheet (annual, 2022-12-31) — Working Capital: -274371.84
MLBON.PA income_statement (annual, 2023-12-31) — +Operating Expense: 66308.59
MLBON.PA income_statement (annual, 2023-12-31) — +Total Revenue: 309374.55
MLBON.PA balance_sheet (annual, 2023-12-31) — Accounts Payable: 299565.12
MLBON.PA balance_sheet (annual, 2023-12-31) — Accounts Receivable: 34985.39
MLBON.PA balance_sheet (annual, 2023-12-31) — Capital Stock: 7063200.00
MLBON.PA balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 9958.61
MLBON.PA balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 9958.61
MLBON.PA balance_sheet (annual, 2023-12-31) — Cash Financial: 9958.61
MLBON.PA balance_sheet (annual, 2023-12-31) — Common Stock: 7063200.00
MLBON.PA balance_sheet (annual, 2023-12-31) — Common Stock Equity: 2680922.78
MLBON.PA income_statement (annual, 2023-12-31) — Cost Of Revenue: 282960.05
MLBON.PA balance_sheet (annual, 2023-12-31) — Current Assets: 92858.95
MLBON.PA balance_sheet (annual, 2023-12-31) — Current Debt: 75000.00
MLBON.PA balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 75000.00
MLBON.PA balance_sheet (annual, 2023-12-31) — Current Liabilities: 411936.17
MLBON.PA income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: -140.87
MLBON.PA income_statement (annual, 2023-12-31) — Depreciation Income Statement: -140.87
MLBON.PA income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -1044705.38
MLBON.PA income_statement (annual, 2023-12-31) — EBIT: -39894.09
MLBON.PA income_statement (annual, 2023-12-31) — EBITDA: -39894.09
MLBON.PA balance_sheet (annual, 2023-12-31) — Finished Goods: 37331.61
MLBON.PA income_statement (annual, 2023-12-31) — Gross Profit: 26414.50
MLBON.PA income_statement (annual, 2023-12-31) — Interest Expense: 1004811.29
MLBON.PA income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 1004811.29
MLBON.PA income_statement (annual, 2023-12-31) — Interest Income: 0.00
MLBON.PA income_statement (annual, 2023-12-31) — Interest Income Non Operating: 0.00
MLBON.PA balance_sheet (annual, 2023-12-31) — Inventory: 37331.61
MLBON.PA balance_sheet (annual, 2023-12-31) — Invested Capital: 2755922.78
MLBON.PA balance_sheet (annual, 2023-12-31) — Investments In Other Ventures Under Equity Method: 3000000.00
MLBON.PA balance_sheet (annual, 2023-12-31) — Investmentsin Associatesat Cost: 3000000.00
MLBON.PA balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 3000000.00
MLBON.PA balance_sheet (annual, 2023-12-31) — Net Debt: 65041.39
MLBON.PA income_statement (annual, 2023-12-31) — Net Income: -1044705.38
MLBON.PA income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -1044705.38
MLBON.PA income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -1044705.38
MLBON.PA income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -1044705.38
MLBON.PA income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -1044705.38
MLBON.PA income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -1044705.38
MLBON.PA income_statement (annual, 2023-12-31) — Net Interest Income: -1004811.29
MLBON.PA income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -1004811.29
MLBON.PA balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 2680922.78
MLBON.PA income_statement (annual, 2023-12-31) — Normalized EBITDA: -39894.09
MLBON.PA income_statement (annual, 2023-12-31) — Normalized Income: -1044705.38
MLBON.PA income_statement (annual, 2023-12-31) — Operating Income: -39894.09
MLBON.PA income_statement (annual, 2023-12-31) — Operating Revenue: 309374.55
MLBON.PA balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 12840.68
MLBON.PA income_statement (annual, 2023-12-31) — Other Operating Expenses: 10590.14
MLBON.PA balance_sheet (annual, 2023-12-31) — Other Receivables: 10583.34
MLBON.PA income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
MLBON.PA balance_sheet (annual, 2023-12-31) — Payables: 310103.65
MLBON.PA income_statement (annual, 2023-12-31) — Pretax Income: -1044705.38
MLBON.PA income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 282960.05
MLBON.PA income_statement (annual, 2023-12-31) — Reconciled Depreciation: -140.87
MLBON.PA income_statement (annual, 2023-12-31) — Rent Expense Supplemental: 9472.43
MLBON.PA balance_sheet (annual, 2023-12-31) — Retained Earnings: -4389617.71
MLBON.PA balance_sheet (annual, 2023-12-31) — Stockholders Equity: 2680922.78
MLBON.PA balance_sheet (annual, 2023-12-31) — Tangible Book Value: 2680922.78
MLBON.PA income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
MLBON.PA income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
MLBON.PA balance_sheet (annual, 2023-12-31) — Total Assets: 3092858.95
MLBON.PA balance_sheet (annual, 2023-12-31) — Total Capitalization: 2680922.78
MLBON.PA balance_sheet (annual, 2023-12-31) — Total Debt: 75000.00
MLBON.PA balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 2680922.78
MLBON.PA income_statement (annual, 2023-12-31) — Total Expenses: 349268.64
MLBON.PA balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 411936.17
MLBON.PA balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 3000000.00
MLBON.PA balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
MLBON.PA income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -39894.09
MLBON.PA balance_sheet (annual, 2023-12-31) — Total Tax Payable: 10538.53
MLBON.PA balance_sheet (annual, 2023-12-31) — Working Capital: -319077.22
MLBON.PA income_statement (annual, 2024-12-31) — +Operating Expense: 57288.89
MLBON.PA income_statement (annual, 2024-12-31) — +Total Revenue: 281483.60
MLBON.PA balance_sheet (annual, 2024-12-31) — Accounts Payable: 311696.92
MLBON.PA balance_sheet (annual, 2024-12-31) — Accounts Receivable: 64166.71
MLBON.PA balance_sheet (annual, 2024-12-31) — Capital Stock: 7063200.00
MLBON.PA balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 5029.65
MLBON.PA balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 5029.65
MLBON.PA balance_sheet (annual, 2024-12-31) — Cash Financial: 5029.65
MLBON.PA balance_sheet (annual, 2024-12-31) — Common Stock: 7063200.00
MLBON.PA balance_sheet (annual, 2024-12-31) — Common Stock Equity: 2644412.87
MLBON.PA income_statement (annual, 2024-12-31) — Cost Of Revenue: 258907.89
MLBON.PA balance_sheet (annual, 2024-12-31) — Current Assets: 340897.27
MLBON.PA balance_sheet (annual, 2024-12-31) — Current Debt: 35965.28
MLBON.PA balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 35965.28
MLBON.PA balance_sheet (annual, 2024-12-31) — Current Liabilities: 674661.54
MLBON.PA income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 0.00
MLBON.PA income_statement (annual, 2024-12-31) — Depreciation Income Statement: 0.00
MLBON.PA income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -36509.91
MLBON.PA income_statement (annual, 2024-12-31) — EBIT: -33732.21
MLBON.PA income_statement (annual, 2024-12-31) — EBITDA: -33732.21
MLBON.PA balance_sheet (annual, 2024-12-31) — Finished Goods: 19872.97
MLBON.PA income_statement (annual, 2024-12-31) — Gross Profit: 22575.71
MLBON.PA income_statement (annual, 2024-12-31) — Interest Expense: 2777.70
MLBON.PA income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 2777.70
MLBON.PA income_statement (annual, 2024-12-31) — Interest Income: 980.97
MLBON.PA income_statement (annual, 2024-12-31) — Interest Income Non Operating: 980.97
MLBON.PA balance_sheet (annual, 2024-12-31) — Inventory: 19872.97
MLBON.PA balance_sheet (annual, 2024-12-31) — Invested Capital: 2680378.15
MLBON.PA balance_sheet (annual, 2024-12-31) — Investments In Other Ventures Under Equity Method: 3000000.00
MLBON.PA balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 3000000.00
MLBON.PA balance_sheet (annual, 2024-12-31) — Net Debt: 30935.63
MLBON.PA income_statement (annual, 2024-12-31) — Net Income: -36509.91
MLBON.PA income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -36509.91
MLBON.PA income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -36509.91
MLBON.PA income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -36509.91
MLBON.PA income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -36509.91
MLBON.PA income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -36509.91
MLBON.PA income_statement (annual, 2024-12-31) — Net Interest Income: -1796.73
MLBON.PA income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -1796.73
MLBON.PA balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 2644412.87
MLBON.PA income_statement (annual, 2024-12-31) — Normalized EBITDA: -33732.21
MLBON.PA income_statement (annual, 2024-12-31) — Normalized Income: -36509.91
MLBON.PA income_statement (annual, 2024-12-31) — Operating Income: -34713.18
MLBON.PA income_statement (annual, 2024-12-31) — Operating Revenue: 281483.60
MLBON.PA balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 306082.68
MLBON.PA balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 21822.86
MLBON.PA income_statement (annual, 2024-12-31) — Other Operating Expenses: 3086.29
MLBON.PA balance_sheet (annual, 2024-12-31) — Other Receivables: 251827.94
MLBON.PA income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
MLBON.PA balance_sheet (annual, 2024-12-31) — Payables: 321435.06
MLBON.PA income_statement (annual, 2024-12-31) — Pretax Income: -36509.91
MLBON.PA income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 258907.89
MLBON.PA income_statement (annual, 2024-12-31) — Reconciled Depreciation: 0.00
MLBON.PA income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 30142.04
MLBON.PA balance_sheet (annual, 2024-12-31) — Retained Earnings: -4426127.62
MLBON.PA balance_sheet (annual, 2024-12-31) — Stockholders Equity: 2644412.87
MLBON.PA balance_sheet (annual, 2024-12-31) — Tangible Book Value: 2644412.87
MLBON.PA income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
MLBON.PA income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
MLBON.PA balance_sheet (annual, 2024-12-31) — Total Assets: 3340897.27
MLBON.PA balance_sheet (annual, 2024-12-31) — Total Capitalization: 2644412.87
MLBON.PA balance_sheet (annual, 2024-12-31) — Total Debt: 35965.28
MLBON.PA balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 2644412.87
MLBON.PA income_statement (annual, 2024-12-31) — Total Expenses: 316196.78
MLBON.PA balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 696484.40
MLBON.PA balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 3000000.00
MLBON.PA balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 21822.86
MLBON.PA income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -34713.18
MLBON.PA balance_sheet (annual, 2024-12-31) — Total Tax Payable: 9738.14
MLBON.PA balance_sheet (annual, 2024-12-31) — Working Capital: -333764.27
MLC.IR income_statement (annual, 2021-12-31) — +Operating Expense: 1700000.00
MLC.IR income_statement (annual, 2021-12-31) — +Total Revenue: 0.00
MLC.IR balance_sheet (annual, 2021-12-31) — Accounts Payable: 100000.00
MLC.IR balance_sheet (annual, 2021-12-31) — Accumulated Depreciation: -400000.00
MLC.IR balance_sheet (annual, 2021-12-31) — Additional Paid In Capital: 112900000.00
MLC.IR cash_flow (annual, 2021-12-31) — Amortization Cash Flow: 3000000.00
MLC.IR balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 165700000.00
MLC.IR income_statement (annual, 2021-12-31) — Basic Average Shares: 44500000.00
MLC.IR income_statement (annual, 2021-12-31) — Basic EPS: 0.85
MLC.IR cash_flow (annual, 2021-12-31) — Beginning Cash Position: 28200000.00
MLC.IR cash_flow (annual, 2021-12-31) — Capital Expenditure: -1600000.00
MLC.IR balance_sheet (annual, 2021-12-31) — Capital Lease Obligations: 100000.00
MLC.IR balance_sheet (annual, 2021-12-31) — Capital Stock: 0.00
MLC.IR balance_sheet (annual, 2021-12-31) — Cash And Cash Equivalents: 32700000.00
MLC.IR balance_sheet (annual, 2021-12-31) — Cash Cash Equivalents And Short Term Investments: 32700000.00
MLC.IR balance_sheet (annual, 2021-12-31) — Cash Financial: 32700000.00
MLC.IR cash_flow (annual, 2021-12-31) — Change In Inventory: 800000.00
MLC.IR cash_flow (annual, 2021-12-31) — Change In Payable: 5100000.00
MLC.IR cash_flow (annual, 2021-12-31) — Change In Receivables: -1500000.00
MLC.IR cash_flow (annual, 2021-12-31) — Change In Working Capital: 4400000.00
MLC.IR cash_flow (annual, 2021-12-31) — Changes In Cash: 17300000.00
MLC.IR balance_sheet (annual, 2021-12-31) — Common Stock: 0.00
MLC.IR balance_sheet (annual, 2021-12-31) — Common Stock Equity: 218900000.00
MLC.IR cash_flow (annual, 2021-12-31) — Common Stock Payments: -95100000.00
MLC.IR balance_sheet (annual, 2021-12-31) — Current Assets: 37900000.00
MLC.IR balance_sheet (annual, 2021-12-31) — Current Capital Lease Obligation: 100000.00
MLC.IR balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 100000.00
MLC.IR balance_sheet (annual, 2021-12-31) — Current Liabilities: 2600000.00
MLC.IR cash_flow (annual, 2021-12-31) — Deferred Tax: -4400000.00
MLC.IR cash_flow (annual, 2021-12-31) — Depreciation: 1100000.00
MLC.IR cash_flow (annual, 2021-12-31) — Depreciation And Amortization: 4100000.00
MLC.IR income_statement (annual, 2021-12-31) — Diluted Average Shares: 44600000.00
MLC.IR income_statement (annual, 2021-12-31) — Diluted EPS: 0.85
MLC.IR income_statement (annual, 2021-12-31) — Diluted NI Availto Com Stockholders: 37800000.00
MLC.IR cash_flow (annual, 2021-12-31) — Dividends Received Cfi: 1000000.00
MLC.IR income_statement (annual, 2021-12-31) — EBIT: -2600000.00
MLC.IR income_statement (annual, 2021-12-31) — EBITDA: 1500000.00
MLC.IR cash_flow (annual, 2021-12-31) — Effect Of Exchange Rate Changes: -500000.00
MLC.IR cash_flow (annual, 2021-12-31) — End Cash Position: 32700000.00
MLC.IR balance_sheet (annual, 2021-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 5400000.00
MLC.IR cash_flow (annual, 2021-12-31) — Financing Cash Flow: -143600000.00
MLC.IR cash_flow (annual, 2021-12-31) — Free Cash Flow: -6200000.00
MLC.IR income_statement (annual, 2021-12-31) — General And Administrative Expense: 1500000.00
MLC.IR balance_sheet (annual, 2021-12-31) — Goodwill: 0.00
MLC.IR balance_sheet (annual, 2021-12-31) — Goodwill And Other Intangible Assets: 100000.00
MLC.IR balance_sheet (annual, 2021-12-31) — Gross PPE: 500000.00
MLC.IR income_statement (annual, 2021-12-31) — Interest Expense: 1200000.00
MLC.IR income_statement (annual, 2021-12-31) — Interest Expense Non Operating: 1200000.00
MLC.IR income_statement (annual, 2021-12-31) — Interest Income: 0.00
MLC.IR income_statement (annual, 2021-12-31) — Interest Income Non Operating: 0.00
MLC.IR cash_flow (annual, 2021-12-31) — Interest Paid Cfo: -1200000.00
MLC.IR balance_sheet (annual, 2021-12-31) — Invested Capital: 218900000.00
MLC.IR cash_flow (annual, 2021-12-31) — Investing Cash Flow: 165500000.00
MLC.IR balance_sheet (annual, 2021-12-31) — Investmentin Financial Assets: 171100000.00
MLC.IR balance_sheet (annual, 2021-12-31) — Investmentsin Associatesat Cost: 15900000.00
MLC.IR cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -47500000.00
MLC.IR balance_sheet (annual, 2021-12-31) — Long Term Equity Investment: 15900000.00
MLC.IR balance_sheet (annual, 2021-12-31) — Machinery Furniture Equipment: 0.00
MLC.IR balance_sheet (annual, 2021-12-31) — Minority Interest: 0.00
MLC.IR income_statement (annual, 2021-12-31) — Minority Interests: 3400000.00
MLC.IR cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: -95100000.00
MLC.IR income_statement (annual, 2021-12-31) — Net Income: 37800000.00
MLC.IR income_statement (annual, 2021-12-31) — Net Income Common Stockholders: 37800000.00
MLC.IR income_statement (annual, 2021-12-31) — Net Income Continuous Operations: -500000.00
MLC.IR income_statement (annual, 2021-12-31) — Net Income Discontinuous Operations: 34900000.00
MLC.IR income_statement (annual, 2021-12-31) — Net Income From Continuing And Discontinued Operation: 37800000.00
MLC.IR income_statement (annual, 2021-12-31) — Net Income From Continuing Operation Net Minority Interest: 2900000.00
MLC.IR cash_flow (annual, 2021-12-31) — Net Income From Continuing Operations: 34400000.00
MLC.IR income_statement (annual, 2021-12-31) — Net Income Including Noncontrolling Interests: 34400000.00
MLC.IR cash_flow (annual, 2021-12-31) — Net Intangibles Purchase And Sale: -800000.00
MLC.IR income_statement (annual, 2021-12-31) — Net Interest Income: -1400000.00
MLC.IR cash_flow (annual, 2021-12-31) — Net Investment Purchase And Sale: 87200000.00
MLC.IR cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: -47500000.00
MLC.IR cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: -47500000.00
MLC.IR income_statement (annual, 2021-12-31) — Net Non Operating Interest Income Expense: -1400000.00
MLC.IR cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -95700000.00
MLC.IR cash_flow (annual, 2021-12-31) — Net Other Investing Changes: 78800000.00
MLC.IR balance_sheet (annual, 2021-12-31) — Net PPE: 100000.00
MLC.IR cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: -700000.00
MLC.IR balance_sheet (annual, 2021-12-31) — Net Tangible Assets: 218800000.00
MLC.IR balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Assets: 3100000.00
MLC.IR balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Liabilities: 3700000.00
MLC.IR income_statement (annual, 2021-12-31) — Normalized EBITDA: 3600000.00